ATE386743T1 - Pyrimidoverbindungen mit antiproliferativer wirkung - Google Patents

Pyrimidoverbindungen mit antiproliferativer wirkung

Info

Publication number
ATE386743T1
ATE386743T1 AT03792269T AT03792269T ATE386743T1 AT E386743 T1 ATE386743 T1 AT E386743T1 AT 03792269 T AT03792269 T AT 03792269T AT 03792269 T AT03792269 T AT 03792269T AT E386743 T1 ATE386743 T1 AT E386743T1
Authority
AT
Austria
Prior art keywords
pyrimid
compounds
antiproliferative effect
antiproliferative
effect
Prior art date
Application number
AT03792269T
Other languages
English (en)
Inventor
Yi Chen
Andrzej Daniewski
William Harris
Marek Kabat
Emily Liu
Jin-Jun Liu
Kin-Chun Luk
Christophe Michoud
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE386743T1 publication Critical patent/ATE386743T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT03792269T 2002-08-14 2003-08-07 Pyrimidoverbindungen mit antiproliferativer wirkung ATE386743T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40351902P 2002-08-14 2002-08-14

Publications (1)

Publication Number Publication Date
ATE386743T1 true ATE386743T1 (de) 2008-03-15

Family

ID=31946709

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03792269T ATE386743T1 (de) 2002-08-14 2003-08-07 Pyrimidoverbindungen mit antiproliferativer wirkung

Country Status (19)

Country Link
US (1) US7084270B2 (de)
EP (1) EP1556384B1 (de)
JP (1) JP2005538141A (de)
KR (1) KR20070087687A (de)
CN (1) CN1323080C (de)
AR (1) AR040971A1 (de)
AT (1) ATE386743T1 (de)
AU (1) AU2003255389A1 (de)
BR (1) BR0313732A (de)
CA (1) CA2494127A1 (de)
DE (1) DE60319255T2 (de)
ES (1) ES2300644T3 (de)
MX (1) MXPA05001629A (de)
PA (1) PA8580001A1 (de)
PL (1) PL375588A1 (de)
RU (1) RU2336275C2 (de)
TW (1) TW200407326A (de)
UY (1) UY27937A1 (de)
WO (1) WO2004018472A2 (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006024486A2 (en) 2004-08-31 2006-03-09 F. Hoffmann-La Roche Ag Amide derivatives of 3-phenyl dihydropyrimido[4,5-d]pyrimidinones, their manufacture and use as pharmaceutical agents
CN1984914A (zh) 2004-08-31 2007-06-20 霍夫曼-拉罗奇有限公司 7-氨基-3-苯基-二氢嘧啶并[4,5-d]嘧啶酮的酰胺衍生物、其制备和作为蛋白激酶抑制剂的应用
EP2400985A2 (de) 2009-02-25 2012-01-04 OSI Pharmaceuticals, LLC Kombination eines anti-igf-1r-antikörpers oder eines igf-bindungsproteins und eines kleinmoleküligen igf-1r-kinase-inhibitors
JP2012519282A (ja) 2009-02-27 2012-08-23 オーエスアイ・ファーマシューティカルズ,エルエルシー 間葉様腫瘍細胞またはその生成を阻害する薬剤を同定するための方法
EP2401614A1 (de) 2009-02-27 2012-01-04 OSI Pharmaceuticals, LLC Verfahren zur identifizierung von mesenchymähnlichen tumorzellen oder deren bildung hemmenden stoffen
WO2010099138A2 (en) 2009-02-27 2010-09-02 Osi Pharmaceuticals, Inc. Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation
WO2012088266A2 (en) 2010-12-22 2012-06-28 Incyte Corporation Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
US9896730B2 (en) 2011-04-25 2018-02-20 OSI Pharmaceuticals, LLC Use of EMT gene signatures in cancer drug discovery, diagnostics, and treatment
CN102816162B (zh) * 2011-06-10 2016-04-27 中国科学院广州生物医药与健康研究院 嘧啶并嘧啶酮类化合物及其药用组合物和应用
WO2013152252A1 (en) 2012-04-06 2013-10-10 OSI Pharmaceuticals, LLC Combination anti-cancer therapy
US9611267B2 (en) 2012-06-13 2017-04-04 Incyte Holdings Corporation Substituted tricyclic compounds as FGFR inhibitors
US9388185B2 (en) 2012-08-10 2016-07-12 Incyte Holdings Corporation Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
CN104968664A (zh) * 2012-12-12 2015-10-07 山东亨利医药科技有限责任公司 作为酪氨酸激酶抑制剂的并环化合物
US9266892B2 (en) 2012-12-19 2016-02-23 Incyte Holdings Corporation Fused pyrazoles as FGFR inhibitors
EP3943087A1 (de) 2013-03-15 2022-01-26 Celgene CAR LLC Heteroarylverbindungen und verwendungen davon
US9321786B2 (en) 2013-03-15 2016-04-26 Celgene Avilomics Research, Inc. Heteroaryl compounds and uses thereof
TWI649318B (zh) 2013-04-19 2019-02-01 英塞特控股公司 作為fgfr抑制劑之雙環雜環
CN104418860B (zh) * 2013-08-20 2016-09-07 中国科学院广州生物医药与健康研究院 嘧啶并杂环类化合物及其药用组合物和应用
MA38393B1 (fr) 2014-03-13 2018-11-30 Sanofi Sa Composés hétéroaryle et utilisations associées
EP3172213B1 (de) 2014-07-21 2021-09-22 Dana-Farber Cancer Institute, Inc. Makrocyclische kinasehemmer und verwendungen davon
WO2016014542A1 (en) 2014-07-21 2016-01-28 Dana-Farber Cancer Institute, Inc. Imidazolyl kinase inhibitors and uses thereof
AU2015300782B2 (en) 2014-08-08 2020-04-16 Dana-Farber Cancer Institute, Inc. Uses of salt-inducible kinase (SIK) inhibitors
US10851105B2 (en) 2014-10-22 2020-12-01 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
MA41551A (fr) 2015-02-20 2017-12-26 Incyte Corp Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
WO2016134294A1 (en) 2015-02-20 2016-08-25 Incyte Corporation Bicyclic heterocycles as fgfr4 inhibitors
AU2016219822B2 (en) 2015-02-20 2020-07-09 Incyte Holdings Corporation Bicyclic heterocycles as FGFR inhibitors
US10954242B2 (en) 2016-07-05 2021-03-23 The Broad Institute, Inc. Bicyclic urea kinase inhibitors and uses thereof
US11241435B2 (en) 2016-09-16 2022-02-08 The General Hospital Corporation Uses of salt-inducible kinase (SIK) inhibitors for treating osteoporosis
US11285158B2 (en) * 2017-02-28 2022-03-29 The General Hospital Corporation Uses of pyrimidopyrimidinones as SIK inhibitors
AR111960A1 (es) 2017-05-26 2019-09-04 Incyte Corp Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
ES2991427T3 (es) 2018-05-04 2024-12-03 Incyte Corp Formas sólidas de un inhibidor de FGFR y procedimientos para preparar las mismas
TW201946630A (zh) 2018-05-04 2019-12-16 美商英塞特公司 Fgfr抑制劑之鹽
US20220098203A1 (en) * 2018-12-27 2022-03-31 Les Laboratoires Servier Sas Aza-heterobicyclic inhibitors of mat2a and methods of use for treating cancer
US11628162B2 (en) 2019-03-08 2023-04-18 Incyte Corporation Methods of treating cancer with an FGFR inhibitor
WO2021007269A1 (en) 2019-07-09 2021-01-14 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
WO2021067374A1 (en) 2019-10-01 2021-04-08 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
GEAP202415945A (en) 2019-10-14 2024-04-25 Incyte Corp Bicyclic heterocycles as fgfr inhibitors
WO2021076728A1 (en) 2019-10-16 2021-04-22 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
CA3163875A1 (en) 2019-12-04 2021-06-10 Incyte Corporation Tricyclic heterocycles as fgfr inhibitors
AU2020395185A1 (en) 2019-12-04 2022-06-02 Incyte Corporation Derivatives of an FGFR inhibitor
WO2021146424A1 (en) 2020-01-15 2021-07-22 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
EP4323405A1 (de) 2021-04-12 2024-02-21 Incyte Corporation Kombinationstherapie mit einem fgfr-inhibitor und einem auf nectin-4 abzielenden mittel
AR126101A1 (es) 2021-06-09 2023-09-13 Incyte Corp Heterociclos tricíclicos como inhibidores de fgfr
CA3220274A1 (en) 2021-06-09 2022-12-15 Incyte Corporation Tricyclic heterocycles as fgfr inhibitors

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2949466A (en) * 1958-03-04 1960-08-16 Parke Davis & Co Pyrimidine compounds and means of producing the same
NL6704601A (de) * 1966-04-06 1967-10-09
US4425346A (en) * 1980-08-01 1984-01-10 Smith And Nephew Associated Companies Limited Pharmaceutical compositions
JPS60226882A (ja) * 1984-04-24 1985-11-12 Nippon Zoki Pharmaceut Co Ltd 新規ピリミドピリミジン誘導体
AU7622698A (en) 1996-12-05 1998-06-29 Sugen, Inc. Use of indolinone compounds as modulators of protein kinases
EE200000706A (et) 1998-05-26 2002-06-17 Warner-Lambert Company Bitsüklilised pürimidiinid ja bitsüklilised 3,4-dihüdropürimidiinid kui rakkude proliferatsiooni inhibiitorid
HK1041483B (zh) * 1998-10-23 2004-12-24 霍夫曼-拉罗奇有限公司 雙環氮雜環
DE60032623T2 (de) 1999-10-21 2007-10-11 F. Hoffmann-La Roche Ag Alkylamino-substituierte bicyclische heterocyclen als p38 protein-kinase-inhibitoren
KR100523120B1 (ko) * 1999-10-21 2005-10-20 에프. 호프만-라 로슈 아게 P38 단백질 키나제 저해제로서 헤테로알킬아미노-치환된이환 질소 헤테로환
MY141144A (en) 2000-03-02 2010-03-15 Smithkline Beecham Corp 1, 5-disubstituted-3,4-dihydro-1h-pyrimido 4,5-dipyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
CA2420286A1 (en) 2000-08-31 2002-03-07 F. Hoffmann-La Roche Ag 7-oxo pyridopyrimidines as inhibitors of a cellular proliferation
PA8577501A1 (es) 2002-07-25 2004-02-07 Warner Lambert Co Inhibidores de quinasas

Also Published As

Publication number Publication date
CN1675214A (zh) 2005-09-28
MXPA05001629A (es) 2005-04-25
PL375588A1 (en) 2005-11-28
UY27937A1 (es) 2004-02-27
JP2005538141A (ja) 2005-12-15
RU2336275C2 (ru) 2008-10-20
AU2003255389A1 (en) 2004-03-11
EP1556384B1 (de) 2008-02-20
EP1556384A2 (de) 2005-07-27
CA2494127A1 (en) 2004-03-04
TW200407326A (en) 2004-05-16
ES2300644T3 (es) 2008-06-16
WO2004018472A3 (en) 2004-04-29
AR040971A1 (es) 2005-04-27
DE60319255D1 (de) 2008-04-03
RU2005107314A (ru) 2005-11-20
CN1323080C (zh) 2007-06-27
BR0313732A (pt) 2005-09-27
PA8580001A1 (es) 2004-03-10
DE60319255T2 (de) 2009-03-05
KR20070087687A (ko) 2007-08-28
US20040038995A1 (en) 2004-02-26
WO2004018472A2 (en) 2004-03-04
US7084270B2 (en) 2006-08-01

Similar Documents

Publication Publication Date Title
ATE386743T1 (de) Pyrimidoverbindungen mit antiproliferativer wirkung
DE60332125D1 (de) Indole mit antidiabetischer wirkung
DE60318287D1 (de) Zerstäuber mit diskreten Strahlen
DE602004029705D1 (de) 5,7-diaminopyrazoloä4,3-düpyrimidine mit pde-5-hemmender wirkung
EP1546115A4 (de) Substituierte pyrimidine
EP1567871A4 (de) Sondenstation mit niederinduktivitätsweg
FI20020394A0 (fi) Valotutka
DK1487805T3 (da) Pyrimidinderivater
DE60319260D1 (de) Pyrimidoderivate mit antiproliferativer aktivität (ii)
ATE473985T1 (de) Tricyclische tetrahydrochinoline mit antibakterieller wirkung
EP1548905A4 (de) Lichtemittierendes element
ATE446750T1 (de) 3-cyano-chinolin-derivate mit antiproliferativer wirkung
DE60328272D1 (de) Diazabicycloalkan-derivate mit nk1-antagonistischer wirkung
DE60315984D1 (de) Substituierte benzisoxazolsulfonamide mit breitbändiger hiv-protease hemmender wirkung
IS7421A (is) Frásogshvati
DE602004017199D1 (de) Silikonverbindungen mit mikrobizider wirkung
FR2844817B1 (fr) Element de coffrage
FI5659U1 (fi) Lana
ITUD20020026U1 (it) Profilo luminoso polifunzionale
ITUD20020081A1 (it) Profilo luminoso polifunzionale
FI5717U1 (fi) Kynttiläteline
ITRE20020018A1 (it) Denocciolatrice
DK1539233T3 (da) Humaniserede super-antistoffer
UA6170S (uk) Профіль
UA6188S (uk) Профіль

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1556384

Country of ref document: EP

REN Ceased due to non-payment of the annual fee